Mechanism of cholinergic potentiation of tranquilizer activity.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004357:Drug Synergism; D004877:Ergoloid Mesylates / Q000494:pharmacology; D006591:Hexobarbital / Q000494:pharmacology*; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D051379:Mice; D009388:Neostigmine / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D010640:Phenothiazines / Q000494:pharmacology*; D011395:Promazine / Q000494:pharmacology; D013757:Tetraethylammonium Compounds / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology*
D002800:Cholinesterase Inhibitors; D010640:Phenothiazines; D013757:Tetraethylammonium Compounds; D014149:Tranquilizing Agents; D009388:Neostigmine; D001285:Atropine; D004877:Ergoloid Mesylates; D008238:Lysergic Acid Diethylamide; D010293:Pargyline; D006591:Hexobarbital; D006916:5-Hydroxytryptophan; D011395:Promazine